Global Anti-amyloid Therapy Supply, Demand and Key Producers, 2024-2030

Description

Anti-amyloid therapy refers to a treatment approach aimed at addressing Alzheimer's disease by targeting and reducing the accumulation of amyloid-beta plaques in the brain. These therapies are designed to modify the disease's progression rather than merely alleviate symptoms. By utilizing agents that bind to amyloid-beta or promote its clearance, anti-amyloid therapies seek to improve cognitive function and slow neurodegeneration in affected individuals. Prominent examples include donanemab and lecanemab, which have been used to treat early stages of Alzheimer’s.

The global Anti-amyloid Therapy market size is expected to reach $ million by 2030, rising at a market growth of %CAGR during the forecast period (2024-2030).

This report studies the global Anti-amyloid Therapy production, demand, key manufacturers, and key regions.

This report is a detailed and comprehensive analysis of the world market for Anti-amyloid Therapy and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2023 as the base year. This report explores demand trends and competition, as well as details the characteristics of Anti-amyloid Therapy that contribute to its increasing demand across many markets.

Highlights and key features of the study
Global Anti-amyloid Therapy total production and demand, 2019-2030, (K Units)
Global Anti-amyloid Therapy total production value, 2019-2030, (USD Million)
Global Anti-amyloid Therapy production by region & country, production, value, CAGR, 2019-2030, (USD Million) & (K Units), (based on production site)
Global Anti-amyloid Therapy consumption by region & country, CAGR, 2019-2030 & (K Units)
U.S. VS China: Anti-amyloid Therapy domestic production, consumption, key domestic manufacturers and share
Global Anti-amyloid Therapy production by manufacturer, production, price, value and market share 2019-2024, (USD Million) & (K Units)
Global Anti-amyloid Therapy production by Type, production, value, CAGR, 2019-2030, (USD Million) & (K Units)
Global Anti-amyloid Therapy production by Application, production, value, CAGR, 2019-2030, (USD Million) & (K Units)
This report profiles key players in the global Anti-amyloid Therapy market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Eisai, Biogen, Eli Lilly, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Anti-amyloid Therapy market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2019-2030 by year with 2023 as the base year, 2024 as the estimate year, and 2025-2030 as the forecast year.

Global Anti-amyloid Therapy Market, By Region:
    United States
    China
    Europe
    Japan
    South Korea
    ASEAN
    India
    Rest of World

Global Anti-amyloid Therapy Market, Segmentation by Type:
    Lecanemab
    Donanemab

Global Anti-amyloid Therapy Market, Segmentation by Application:
    Hospital
    Clinic
    Other

Companies Profiled:
    Eisai
    Biogen
    Eli Lilly

Key Questions Answered:
1. How big is the global Anti-amyloid Therapy market?
2. What is the demand of the global Anti-amyloid Therapy market?
3. What is the year over year growth of the global Anti-amyloid Therapy market?
4. What is the production and production value of the global Anti-amyloid Therapy market?
5. Who are the key producers in the global Anti-amyloid Therapy market?
6. What are the growth factors driving the market demand?

Table of Contents

1 Supply Summary
    1.1 Anti-amyloid Therapy Introduction
    1.2 World Anti-amyloid Therapy Supply & Forecast
        1.2.1 World Anti-amyloid Therapy Production Value (2019 & 2023 & 2030)
        1.2.2 World Anti-amyloid Therapy Production (2019-2030)
        1.2.3 World Anti-amyloid Therapy Pricing Trends (2019-2030)
    1.3 World Anti-amyloid Therapy Production by Region (Based on Production Site)
        1.3.1 World Anti-amyloid Therapy Production Value by Region (2019-2030)
        1.3.2 World Anti-amyloid Therapy Production by Region (2019-2030)
        1.3.3 World Anti-amyloid Therapy Average Price by Region (2019-2030)
        1.3.4 North America Anti-amyloid Therapy Production (2019-2030)
        1.3.5 Europe Anti-amyloid Therapy Production (2019-2030)
        1.3.6 China Anti-amyloid Therapy Production (2019-2030)
        1.3.7 Japan Anti-amyloid Therapy Production (2019-2030)
    1.4 Market Drivers, Restraints and Trends
        1.4.1 Anti-amyloid Therapy Market Drivers
        1.4.2 Factors Affecting Demand
        1.4.3 Anti-amyloid Therapy Major Market Trends

2 Demand Summary
    2.1 World Anti-amyloid Therapy Demand (2019-2030)
    2.2 World Anti-amyloid Therapy Consumption by Region
        2.2.1 World Anti-amyloid Therapy Consumption by Region (2019-2024)
        2.2.2 World Anti-amyloid Therapy Consumption Forecast by Region (2025-2030)
    2.3 United States Anti-amyloid Therapy Consumption (2019-2030)
    2.4 China Anti-amyloid Therapy Consumption (2019-2030)
    2.5 Europe Anti-amyloid Therapy Consumption (2019-2030)
    2.6 Japan Anti-amyloid Therapy Consumption (2019-2030)
    2.7 South Korea Anti-amyloid Therapy Consumption (2019-2030)
    2.8 ASEAN Anti-amyloid Therapy Consumption (2019-2030)
    2.9 India Anti-amyloid Therapy Consumption (2019-2030)

3 World Manufacturers Competitive Analysis
    3.1 World Anti-amyloid Therapy Production Value by Manufacturer (2019-2024)
    3.2 World Anti-amyloid Therapy Production by Manufacturer (2019-2024)
    3.3 World Anti-amyloid Therapy Average Price by Manufacturer (2019-2024)
    3.4 Anti-amyloid Therapy Company Evaluation Quadrant
    3.5 Industry Rank and Concentration Rate (CR)
        3.5.1 Global Anti-amyloid Therapy Industry Rank of Major Manufacturers
        3.5.2 Global Concentration Ratios (CR4) for Anti-amyloid Therapy in 2023
        3.5.3 Global Concentration Ratios (CR8) for Anti-amyloid Therapy in 2023
    3.6 Anti-amyloid Therapy Market: Overall Company Footprint Analysis
        3.6.1 Anti-amyloid Therapy Market: Region Footprint
        3.6.2 Anti-amyloid Therapy Market: Company Product Type Footprint
        3.6.3 Anti-amyloid Therapy Market: Company Product Application Footprint
    3.7 Competitive Environment
        3.7.1 Historical Structure of the Industry
        3.7.2 Barriers of Market Entry
        3.7.3 Factors of Competition
    3.8 New Entrant and Capacity Expansion Plans
    3.9 Mergers, Acquisition, Agreements, and Collaborations

4 United States VS China VS Rest of the World
    4.1 United States VS China: Anti-amyloid Therapy Production Value Comparison
        4.1.1 United States VS China: Anti-amyloid Therapy Production Value Comparison (2019 & 2023 & 2030)
        4.1.2 United States VS China: Anti-amyloid Therapy Production Value Market Share Comparison (2019 & 2023 & 2030)
    4.2 United States VS China: Anti-amyloid Therapy Production Comparison
        4.2.1 United States VS China: Anti-amyloid Therapy Production Comparison (2019 & 2023 & 2030)
        4.2.2 United States VS China: Anti-amyloid Therapy Production Market Share Comparison (2019 & 2023 & 2030)
    4.3 United States VS China: Anti-amyloid Therapy Consumption Comparison
        4.3.1 United States VS China: Anti-amyloid Therapy Consumption Comparison (2019 & 2023 & 2030)
        4.3.2 United States VS China: Anti-amyloid Therapy Consumption Market Share Comparison (2019 & 2023 & 2030)
    4.4 United States Based Anti-amyloid Therapy Manufacturers and Market Share, 2019-2024
        4.4.1 United States Based Anti-amyloid Therapy Manufacturers, Headquarters and Production Site (States, Country)
        4.4.2 United States Based Manufacturers Anti-amyloid Therapy Production Value (2019-2024)
        4.4.3 United States Based Manufacturers Anti-amyloid Therapy Production (2019-2024)
    4.5 China Based Anti-amyloid Therapy Manufacturers and Market Share
        4.5.1 China Based Anti-amyloid Therapy Manufacturers, Headquarters and Production Site (Province, Country)
        4.5.2 China Based Manufacturers Anti-amyloid Therapy Production Value (2019-2024)
        4.5.3 China Based Manufacturers Anti-amyloid Therapy Production (2019-2024)
    4.6 Rest of World Based Anti-amyloid Therapy Manufacturers and Market Share, 2019-2024
        4.6.1 Rest of World Based Anti-amyloid Therapy Manufacturers, Headquarters and Production Site (State, Country)
        4.6.2 Rest of World Based Manufacturers Anti-amyloid Therapy Production Value (2019-2024)
        4.6.3 Rest of World Based Manufacturers Anti-amyloid Therapy Production (2019-2024)

5 Market Analysis by Type
    5.1 World Anti-amyloid Therapy Market Size Overview by Type: 2019 VS 2023 VS 2030
    5.2 Segment Introduction by Type
        5.2.1 Lecanemab
        5.2.2 Donanemab
    5.3 Market Segment by Type
        5.3.1 World Anti-amyloid Therapy Production by Type (2019-2030)
        5.3.2 World Anti-amyloid Therapy Production Value by Type (2019-2030)
        5.3.3 World Anti-amyloid Therapy Average Price by Type (2019-2030)

6 Market Analysis by Application
    6.1 World Anti-amyloid Therapy Market Size Overview by Application: 2019 VS 2023 VS 2030
    6.2 Segment Introduction by Application
        6.2.1 Hospital
        6.2.2 Clinic
        6.2.3 Other
    6.3 Market Segment by Application
        6.3.1 World Anti-amyloid Therapy Production by Application (2019-2030)
        6.3.2 World Anti-amyloid Therapy Production Value by Application (2019-2030)
        6.3.3 World Anti-amyloid Therapy Average Price by Application (2019-2030)

7 Company Profiles
    7.1 Eisai
        7.1.1 Eisai Details
        7.1.2 Eisai Major Business
        7.1.3 Eisai Anti-amyloid Therapy Product and Services
        7.1.4 Eisai Anti-amyloid Therapy Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.1.5 Eisai Recent Developments/Updates
        7.1.6 Eisai Competitive Strengths & Weaknesses
    7.2 Biogen
        7.2.1 Biogen Details
        7.2.2 Biogen Major Business
        7.2.3 Biogen Anti-amyloid Therapy Product and Services
        7.2.4 Biogen Anti-amyloid Therapy Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.2.5 Biogen Recent Developments/Updates
        7.2.6 Biogen Competitive Strengths & Weaknesses
    7.3 Eli Lilly
        7.3.1 Eli Lilly Details
        7.3.2 Eli Lilly Major Business
        7.3.3 Eli Lilly Anti-amyloid Therapy Product and Services
        7.3.4 Eli Lilly Anti-amyloid Therapy Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.3.5 Eli Lilly Recent Developments/Updates
        7.3.6 Eli Lilly Competitive Strengths & Weaknesses

8 Industry Chain Analysis
    8.1 Anti-amyloid Therapy Industry Chain
    8.2 Anti-amyloid Therapy Upstream Analysis
        8.2.1 Anti-amyloid Therapy Core Raw Materials
        8.2.2 Main Manufacturers of Anti-amyloid Therapy Core Raw Materials
    8.3 Midstream Analysis
    8.4 Downstream Analysis
    8.5 Anti-amyloid Therapy Production Mode
    8.6 Anti-amyloid Therapy Procurement Model
    8.7 Anti-amyloid Therapy Industry Sales Model and Sales Channels
        8.7.1 Anti-amyloid Therapy Sales Model
        8.7.2 Anti-amyloid Therapy Typical Distributors

9 Research Findings and Conclusion

10 Appendix
    10.1 Methodology
    10.2 Research Process and Data Source
    10.3 Disclaimer

Table of Figures

List of Tables
 Table 1. World Anti-amyloid Therapy Production Value by Region (2019, 2023 and 2030) & (USD Million)
 Table 2. World Anti-amyloid Therapy Production Value by Region (2019-2024) & (USD Million)
 Table 3. World Anti-amyloid Therapy Production Value by Region (2025-2030) & (USD Million)
 Table 4. World Anti-amyloid Therapy Production Value Market Share by Region (2019-2024)
 Table 5. World Anti-amyloid Therapy Production Value Market Share by Region (2025-2030)
 Table 6. World Anti-amyloid Therapy Production by Region (2019-2024) & (K Units)
 Table 7. World Anti-amyloid Therapy Production by Region (2025-2030) & (K Units)
 Table 8. World Anti-amyloid Therapy Production Market Share by Region (2019-2024)
 Table 9. World Anti-amyloid Therapy Production Market Share by Region (2025-2030)
 Table 10. World Anti-amyloid Therapy Average Price by Region (2019-2024) & (US$/Unit)
 Table 11. World Anti-amyloid Therapy Average Price by Region (2025-2030) & (US$/Unit)
 Table 12. Anti-amyloid Therapy Major Market Trends
 Table 13. World Anti-amyloid Therapy Consumption Growth Rate Forecast by Region (2019 & 2023 & 2030) & (K Units)
 Table 14. World Anti-amyloid Therapy Consumption by Region (2019-2024) & (K Units)
 Table 15. World Anti-amyloid Therapy Consumption Forecast by Region (2025-2030) & (K Units)
 Table 16. World Anti-amyloid Therapy Production Value by Manufacturer (2019-2024) & (USD Million)
 Table 17. Production Value Market Share of Key Anti-amyloid Therapy Producers in 2023
 Table 18. World Anti-amyloid Therapy Production by Manufacturer (2019-2024) & (K Units)
 Table 19. Production Market Share of Key Anti-amyloid Therapy Producers in 2023
 Table 20. World Anti-amyloid Therapy Average Price by Manufacturer (2019-2024) & (US$/Unit)
 Table 21. Global Anti-amyloid Therapy Company Evaluation Quadrant
 Table 22. World Anti-amyloid Therapy Industry Rank of Major Manufacturers, Based on Production Value in 2023
 Table 23. Head Office and Anti-amyloid Therapy Production Site of Key Manufacturer
 Table 24. Anti-amyloid Therapy Market: Company Product Type Footprint
 Table 25. Anti-amyloid Therapy Market: Company Product Application Footprint
 Table 26. Anti-amyloid Therapy Competitive Factors
 Table 27. Anti-amyloid Therapy New Entrant and Capacity Expansion Plans
 Table 28. Anti-amyloid Therapy Mergers & Acquisitions Activity
 Table 29. United States VS China Anti-amyloid Therapy Production Value Comparison, (2019 & 2023 & 2030) & (USD Million)
 Table 30. United States VS China Anti-amyloid Therapy Production Comparison, (2019 & 2023 & 2030) & (K Units)
 Table 31. United States VS China Anti-amyloid Therapy Consumption Comparison, (2019 & 2023 & 2030) & (K Units)
 Table 32. United States Based Anti-amyloid Therapy Manufacturers, Headquarters and Production Site (States, Country)
 Table 33. United States Based Manufacturers Anti-amyloid Therapy Production Value, (2019-2024) & (USD Million)
 Table 34. United States Based Manufacturers Anti-amyloid Therapy Production Value Market Share (2019-2024)
 Table 35. United States Based Manufacturers Anti-amyloid Therapy Production (2019-2024) & (K Units)
 Table 36. United States Based Manufacturers Anti-amyloid Therapy Production Market Share (2019-2024)
 Table 37. China Based Anti-amyloid Therapy Manufacturers, Headquarters and Production Site (Province, Country)
 Table 38. China Based Manufacturers Anti-amyloid Therapy Production Value, (2019-2024) & (USD Million)
 Table 39. China Based Manufacturers Anti-amyloid Therapy Production Value Market Share (2019-2024)
 Table 40. China Based Manufacturers Anti-amyloid Therapy Production, (2019-2024) & (K Units)
 Table 41. China Based Manufacturers Anti-amyloid Therapy Production Market Share (2019-2024)
 Table 42. Rest of World Based Anti-amyloid Therapy Manufacturers, Headquarters and Production Site (State, Country)
 Table 43. Rest of World Based Manufacturers Anti-amyloid Therapy Production Value, (2019-2024) & (USD Million)
 Table 44. Rest of World Based Manufacturers Anti-amyloid Therapy Production Value Market Share (2019-2024)
 Table 45. Rest of World Based Manufacturers Anti-amyloid Therapy Production, (2019-2024) & (K Units)
 Table 46. Rest of World Based Manufacturers Anti-amyloid Therapy Production Market Share (2019-2024)
 Table 47. World Anti-amyloid Therapy Production Value by Type, (USD Million), 2019 & 2023 & 2030
 Table 48. World Anti-amyloid Therapy Production by Type (2019-2024) & (K Units)
 Table 49. World Anti-amyloid Therapy Production by Type (2025-2030) & (K Units)
 Table 50. World Anti-amyloid Therapy Production Value by Type (2019-2024) & (USD Million)
 Table 51. World Anti-amyloid Therapy Production Value by Type (2025-2030) & (USD Million)
 Table 52. World Anti-amyloid Therapy Average Price by Type (2019-2024) & (US$/Unit)
 Table 53. World Anti-amyloid Therapy Average Price by Type (2025-2030) & (US$/Unit)
 Table 54. World Anti-amyloid Therapy Production Value by Application, (USD Million), 2019 & 2023 & 2030
 Table 55. World Anti-amyloid Therapy Production by Application (2019-2024) & (K Units)
 Table 56. World Anti-amyloid Therapy Production by Application (2025-2030) & (K Units)
 Table 57. World Anti-amyloid Therapy Production Value by Application (2019-2024) & (USD Million)
 Table 58. World Anti-amyloid Therapy Production Value by Application (2025-2030) & (USD Million)
 Table 59. World Anti-amyloid Therapy Average Price by Application (2019-2024) & (US$/Unit)
 Table 60. World Anti-amyloid Therapy Average Price by Application (2025-2030) & (US$/Unit)
 Table 61. Eisai Basic Information, Manufacturing Base and Competitors
 Table 62. Eisai Major Business
 Table 63. Eisai Anti-amyloid Therapy Product and Services
 Table 64. Eisai Anti-amyloid Therapy Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
 Table 65. Eisai Recent Developments/Updates
 Table 66. Eisai Competitive Strengths & Weaknesses
 Table 67. Biogen Basic Information, Manufacturing Base and Competitors
 Table 68. Biogen Major Business
 Table 69. Biogen Anti-amyloid Therapy Product and Services
 Table 70. Biogen Anti-amyloid Therapy Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
 Table 71. Biogen Recent Developments/Updates
 Table 72. Biogen Competitive Strengths & Weaknesses
 Table 73. Eli Lilly Basic Information, Manufacturing Base and Competitors
 Table 74. Eli Lilly Major Business
 Table 75. Eli Lilly Anti-amyloid Therapy Product and Services
 Table 76. Eli Lilly Anti-amyloid Therapy Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
 Table 77. Eli Lilly Recent Developments/Updates
 Table 78. Eli Lilly Competitive Strengths & Weaknesses
 Table 79. Global Key Players of Anti-amyloid Therapy Upstream (Raw Materials)
 Table 80. Global Anti-amyloid Therapy Typical Customers
 Table 81. Anti-amyloid Therapy Typical Distributors


List of Figures
 Figure 1. Anti-amyloid Therapy Picture
 Figure 2. World Anti-amyloid Therapy Production Value: 2019 & 2023 & 2030, (USD Million)
 Figure 3. World Anti-amyloid Therapy Production Value and Forecast (2019-2030) & (USD Million)
 Figure 4. World Anti-amyloid Therapy Production (2019-2030) & (K Units)
 Figure 5. World Anti-amyloid Therapy Average Price (2019-2030) & (US$/Unit)
 Figure 6. World Anti-amyloid Therapy Production Value Market Share by Region (2019-2030)
 Figure 7. World Anti-amyloid Therapy Production Market Share by Region (2019-2030)
 Figure 8. North America Anti-amyloid Therapy Production (2019-2030) & (K Units)
 Figure 9. Europe Anti-amyloid Therapy Production (2019-2030) & (K Units)
 Figure 10. China Anti-amyloid Therapy Production (2019-2030) & (K Units)
 Figure 11. Japan Anti-amyloid Therapy Production (2019-2030) & (K Units)
 Figure 12. Anti-amyloid Therapy Market Drivers
 Figure 13. Factors Affecting Demand
 Figure 14. World Anti-amyloid Therapy Consumption (2019-2030) & (K Units)
 Figure 15. World Anti-amyloid Therapy Consumption Market Share by Region (2019-2030)
 Figure 16. United States Anti-amyloid Therapy Consumption (2019-2030) & (K Units)
 Figure 17. China Anti-amyloid Therapy Consumption (2019-2030) & (K Units)
 Figure 18. Europe Anti-amyloid Therapy Consumption (2019-2030) & (K Units)
 Figure 19. Japan Anti-amyloid Therapy Consumption (2019-2030) & (K Units)
 Figure 20. South Korea Anti-amyloid Therapy Consumption (2019-2030) & (K Units)
 Figure 21. ASEAN Anti-amyloid Therapy Consumption (2019-2030) & (K Units)
 Figure 22. India Anti-amyloid Therapy Consumption (2019-2030) & (K Units)
 Figure 23. Producer Shipments of Anti-amyloid Therapy by Manufacturer Revenue ($MM) and Market Share (%): 2023
 Figure 24. Global Four-firm Concentration Ratios (CR4) for Anti-amyloid Therapy Markets in 2023
 Figure 25. Global Four-firm Concentration Ratios (CR8) for Anti-amyloid Therapy Markets in 2023
 Figure 26. United States VS China: Anti-amyloid Therapy Production Value Market Share Comparison (2019 & 2023 & 2030)
 Figure 27. United States VS China: Anti-amyloid Therapy Production Market Share Comparison (2019 & 2023 & 2030)
 Figure 28. United States VS China: Anti-amyloid Therapy Consumption Market Share Comparison (2019 & 2023 & 2030)
 Figure 29. United States Based Manufacturers Anti-amyloid Therapy Production Market Share 2023
 Figure 30. China Based Manufacturers Anti-amyloid Therapy Production Market Share 2023
 Figure 31. Rest of World Based Manufacturers Anti-amyloid Therapy Production Market Share 2023
 Figure 32. World Anti-amyloid Therapy Production Value by Type, (USD Million), 2019 & 2023 & 2030
 Figure 33. World Anti-amyloid Therapy Production Value Market Share by Type in 2023
 Figure 34. Lecanemab
 Figure 35. Donanemab
 Figure 36. World Anti-amyloid Therapy Production Market Share by Type (2019-2030)
 Figure 37. World Anti-amyloid Therapy Production Value Market Share by Type (2019-2030)
 Figure 38. World Anti-amyloid Therapy Average Price by Type (2019-2030) & (US$/Unit)
 Figure 39. World Anti-amyloid Therapy Production Value by Application, (USD Million), 2019 & 2023 & 2030
 Figure 40. World Anti-amyloid Therapy Production Value Market Share by Application in 2023
 Figure 41. Hospital
 Figure 42. Clinic
 Figure 43. Other
 Figure 44. World Anti-amyloid Therapy Production Market Share by Application (2019-2030)
 Figure 45. World Anti-amyloid Therapy Production Value Market Share by Application (2019-2030)
 Figure 46. World Anti-amyloid Therapy Average Price by Application (2019-2030) & (US$/Unit)
 Figure 47. Anti-amyloid Therapy Industry Chain
 Figure 48. Anti-amyloid Therapy Procurement Model
 Figure 49. Anti-amyloid Therapy Sales Model
 Figure 50. Anti-amyloid Therapy Sales Channels, Direct Sales, and Distribution
 Figure 51. Methodology
 Figure 52. Research Process and Data Source

Companies Mentioned

Eisai
Biogen
Eli Lilly